Clinical Trials Directory

Trials / Terminated

TerminatedNCT01627353

Post Hysterectomy Pain Prevention: Pre-op Wound Infiltration With Anesthetic Protocol Versus Standard of Care

Post Hysterectomy Pain Prevention: Randomized Clinical Trial of High Volume Preoperative Wound Infiltration and Pain Specific Anesthetic Protocol Versus Standard of Care (no Wound Infiltration and Routine Anesthetic Protocol)

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Calgary · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a blinded randomized clinical trial, comparing policies of high volume preemptive wound infiltration with a specific anesthetic cocktail versus standard of care (no wound infiltration and routine anesthesia) for post operative pain management after hysterectomy. Morphine use and pain will be measured during index admission, and pain will also be measured six weeks postoperatively. The study will be conducted at a single site, Rockyview General Hospital.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard of careCurrent Standard of Care at Rockyview General Hospital for Post Hysterectomy Pain Prevention(no wound infiltration and routine anesthetic protocol).
PROCEDUREPre-emptive wound infiltrationThe Wound Infiltration Group will receive 100 mL 0.125% marcaine plain distributed as follows: 50 mL subcutaneously prior to skin incision along entire length of planned incision line, 50 mL subfascially prior to fascial incision, with 10 mL infiltrated directly into the rectus muscles bilaterally. The Anesthetic will be given as determined appropriate to the patient by the staff anesthetist with the addition of the following: 2 grams of Magnesium Sulphate, 10 mg of Dexamethasone, and 3 mg/kg of Lidocaine, half of which is given on induction and half of which is infused throughout the remainder of the case.

Timeline

Start date
2012-01-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2012-06-25
Last updated
2014-06-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01627353. Inclusion in this directory is not an endorsement.